![](/img/cover-not-exists.png)
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
Yuen, Man-Fung, Agarwal, Kosh, Gane, Edward J, Schwabe, Christian, Ahn, Sang Hoon, Kim, Dong Joon, Lim, Young-Suk, Cheng, Wendy, Sievert, William, Visvanathan, Kumar, Ruby, Eric, Liaw, Sandy, Yan, RanLanguage:
english
Journal:
The Lancet Gastroenterology & Hepatology
DOI:
10.1016/S2468-1253(19)30346-2
Date:
November, 2019
File:
PDF, 1.99 MB
english, 2019